These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37290632)

  • 1. Antineoplastic drugs in urban wastewater: Occurrence, nanofiltration treatment and toxicity screening.
    Gouveia TIA; Cristóvão MB; Pereira VJ; Crespo JG; Alves A; Ribeiro AR; Silva A; Santos MSF
    Environ Pollut; 2023 Sep; 332():121944. PubMed ID: 37290632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of selected pharmaceuticals in wastewater treatment plants of Tuscany: An effect-based approach to evaluate the potential environmental impact.
    Palli L; Spina F; Varese GC; Vincenzi M; Aragno M; Arcangeli G; Mucci N; Santianni D; Caffaz S; Gori R
    Int J Hyg Environ Health; 2019 May; 222(4):717-725. PubMed ID: 31101503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of pharmaceuticals, hazard assessment and ecotoxicological evaluation of wastewater treatment plants in Costa Rica.
    Ramírez-Morales D; Masís-Mora M; Montiel-Mora JR; Cambronero-Heinrichs JC; Briceño-Guevara S; Rojas-Sánchez CE; Méndez-Rivera M; Arias-Mora V; Tormo-Budowski R; Brenes-Alfaro L; Rodríguez-Rodríguez CE
    Sci Total Environ; 2020 Dec; 746():141200. PubMed ID: 32771760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents.
    Gouveia TIA; Gorito AM; Cristóvão MB; Pereira VJ; Crespo J; Alves A; Pereira MFR; Ribeiro ARL; Silva AMT; Santos MSF
    J Environ Manage; 2023 Dec; 348():119314. PubMed ID: 37857217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes.
    Gros M; Petrović M; Ginebreda A; Barceló D
    Environ Int; 2010 Jan; 36(1):15-26. PubMed ID: 19819553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac.
    Schröder P; Helmreich B; Škrbić B; Carballa M; Papa M; Pastore C; Emre Z; Oehmen A; Langenhoff A; Molinos M; Dvarioniene J; Huber C; Tsagarakis KP; Martinez-Lopez E; Pagano SM; Vogelsang C; Mascolo G
    Environ Sci Pollut Res Int; 2016 Jul; 23(13):12835-66. PubMed ID: 27023823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cytotoxicity following oxidative treatment of pharmaceutical residues in wastewater.
    Graumans MHF; van Hove H; Schirris T; Hoeben WFLM; van Dael MFP; Anzion RBM; Russel FGM; Scheepers PTJ
    Chemosphere; 2022 Sep; 303(Pt 2):135022. PubMed ID: 35618071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment.
    Kosma CI; Lambropoulou DA; Albanis TA
    Sci Total Environ; 2014 Jan; 466-467():421-38. PubMed ID: 23933429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposure of pharmaceuticals and musk fragrances in the Somes River before and after upgrading the municipal wastewater treatment plant Cluj-Napoca, Romania.
    Moldovan Z; Chira R; Alder AC
    Environ Sci Pollut Res Int; 2009 Aug; 16 Suppl 1():S46-54. PubMed ID: 18972147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradations of endocrine-disrupting chemicals and pharmaceutical compounds in wastewater with carbon-based nanomaterials: a critical review.
    Ojha A; Tiwary D; Oraon R; Singh P
    Environ Sci Pollut Res Int; 2021 Jun; 28(24):30573-30594. PubMed ID: 33909248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation.
    Naddeo V; Meriç S; Kassinos D; Belgiorno V; Guida M
    Water Res; 2009 Sep; 43(16):4019-27. PubMed ID: 19589554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective environmental risk assessment of mixtures in wastewater treatment plant effluents - Theoretical considerations and experimental verification.
    Coors A; Vollmar P; Sacher F; Polleichtner C; Hassold E; Gildemeister D; Kühnen U
    Water Res; 2018 Sep; 140():56-66. PubMed ID: 29684702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a semi-quantitative risk assessment model for evaluating environmental threat posed by the three first EU watch-list pharmaceuticals to urban wastewater treatment plants: An Irish case study.
    Tahar A; Tiedeken EJ; Clifford E; Cummins E; Rowan N
    Sci Total Environ; 2017 Dec; 603-604():627-638. PubMed ID: 28654878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unravelling the performance of UV/H
    Cibati A; Gonzalez-Olmos R; Rodriguez-Mozaz S; Buttiglieri G
    Chemosphere; 2022 Mar; 290():133315. PubMed ID: 34921855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence and environmental impact of pharmaceutical residues from conventional and natural wastewater treatment plants in Gran Canaria (Spain).
    Afonso-Olivares C; Sosa-Ferrera Z; Santana-Rodríguez JJ
    Sci Total Environ; 2017 Dec; 599-600():934-943. PubMed ID: 28505885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of selected pharmaceuticals in hospital and municipal wastewater effluent: occurrence, removal, and environmental risk assessment.
    Ulvi A; Aydın S; Aydın ME
    Environ Sci Pollut Res Int; 2022 Oct; 29(50):75609-75625. PubMed ID: 35655023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of dissolved organic carbon (DOC) in the wastewater treatment process and its importance in the removal of wastewater contaminants.
    Katsoyiannis A; Samara C
    Environ Sci Pollut Res Int; 2007 Jul; 14(5):284-92. PubMed ID: 17722762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis and advanced oxidation treatment of a persistent pharmaceutical compound in wastewater and wastewater sludge-carbamazepine.
    Mohapatra DP; Brar SK; Tyagi RD; Picard P; Surampalli RY
    Sci Total Environ; 2014 Feb; 470-471():58-75. PubMed ID: 24140682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing hospital impact on pharmaceutical levels in a rural 'source-to-sink' water system.
    Niemi L; Taggart M; Boyd K; Zhang Z; Gaffney PPJ; Pfleger S; Gibb S
    Sci Total Environ; 2020 Oct; 737():139618. PubMed ID: 32534267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and distribution of pharmaceuticals in wastewater from households, livestock farms, hospitals and pharmaceutical manufactures.
    Sim WJ; Lee JW; Lee ES; Shin SK; Hwang SR; Oh JE
    Chemosphere; 2011 Jan; 82(2):179-86. PubMed ID: 21040946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.